Discussion about this post

User's avatar
Ginny Crisp's avatar

Your point about the futility of "appeal every denial" as a patient-level strategy is exactly right. The aggregate solution is not individual appeal volume; it is plan-level visibility and accountability. And the plan sponsor lever for that is contractual, not legislative.

Self-funded employers cover more than 100 million Americans through ERISA-preempted plans. Most contract with a carrier as TPA and a PBM as the pharmacy administrator. Most of those contracts do not require denial reporting by service category, do not require appeal and overturn rate reporting, and do not specify independent medical review thresholds. Those are contract terms an employer can negotiate at renewal today, without waiting for Congress.

Your independent-board proposal is structurally sound, and worth noting that the contract version of it already exists in some Centers of Excellence arrangements where high-cost specialty decisions go to a salaried external clinical reviewer the plan controls. It is rare. It does not have to be.

The contract lever does not solve PA at the system level. But it removes the "we are powerless" frame for the largest single bloc of insured Americans. Worth naming.

Kevin Mowll's avatar

Let me begin with a disclaimer: I am not a fan of United Healthcare. However, to give them their due, I noticed a positive posting about this topic of referrals today in FierceHealth that deserves mention. https://www.fiercehealthcare.com/payers/unitedhealthcare-reduce-prior-auth-requirements-30?utm_medium=email&utm_source=nl&utm_campaign=HC-NL-FierceHealthPayer&oly_enc_id=5345J6883012C3J

4 more comments...

No posts

Ready for more?